Cite

HARVARD Citation

    Takezaki, T. et al. (2021). Reduction of cycles of bendamustine plus rituximab therapy in the cases with good response for indolent B‐cell lymphomas. Hematological oncology. 39 (4), pp. 465-472. [Online]. 
  
Back to record